PTIX: Protagenic Therapeutics, Inc. Stock

by  •  • Comments Off on PTIX: Protagenic Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 2.19
Enterprise Value ($M) 1.13
Book Value ($M) 0.72
Book Value / Share 0.11
Price / Book 3.04
NCAV ($M) 0.63
NCAV / Share 0.09
Price / NCAV 3.46

Profitability (mra)
Return on Invested Capital (ROIC) -7.85
Return on Assets (ROA) -1.31
Return on Equity (ROE) -1.54

Liquidity (mrq)
Quick Ratio 1.80
Current Ratio 1.80

Balance Sheet (mrq) ($M)
Current Assets 1.42
Assets 1.51
Liabilities 0.79
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income 0.00
Net Income 0.00
Earnings Per Share Basic And Diluted n/a

Cash Flow Statement (mra) ($M)
Cash From Operations 0.00
Cash from Investing 0.00
Cash from Financing 0.00

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
02-14 13G/A Armistice Capital, Llc 3.41 0.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-11-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-15 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q
2024-05-14 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A
2024-04-24 10-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K/A
2024-04-01 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-K

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-03-10 94,220 330,322 28.52
2025-03-07 32,615 356,496 9.15
2025-03-06 418,757 1,274,359 32.86
2025-03-05 535,305 1,936,433 27.64

(click for more detail)

Similar Companies
PRPH – ProPhase Labs, Inc. PRQR – ProQR Therapeutics N.V.
PRTG – Portage Biotech Inc. PTPI – Petros Pharmaceuticals, Inc.
PULM – Pulmatrix, Inc.


Financial data and stock pages provided by
Fintel.io